entertainment -WSS

entertainment

author：knowledge 2025-09-29 21:14:15 - browse：6487

Adobe

CVS Health viewed Amy Bricker as a potential CEO. But she won’t be going to the health care conglomerate anytime soon.

A federal appeals court has ruled Bricker, a former high-ranking executive at Cigna, cannot jump to CVS because it would violate her noncompete agreement that she signed while at Cigna. The appeals court’s decision backs up what a district court had previously ruled.

The case is a prominent example of why the health care industry, and corporate America writ large, does not want noncompetes to go away. In April, the Federal Trade Commission approved a nationwide ban on most such agreements, which prevent workers from moving to other jobs, but companies and corporate lobbying groups have already sued to squash the ban.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Readout Newsletter: Merck, J&J, and long Covid

focus

WSS

Parkinson’s finding may lead to tests and, someday, treatments

Making the case for fair compensation in clinical trials

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

Independent physicians launch a new lobbying group

Think you might have Covid

Making the case for fair compensation in clinical trials

explore

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

knowledge

Duchenne breakthrough therapy leaves behind pioneering families

H5N1 bird flu outbreak: Second human case reported, in Michigan

Hepatitis C has a cure — but many Americans still lack access to it

eGenesis tests gene

Guidelines to prevent youth baseball injuries need more muscle

Prior authorization will have to move faster under new Biden rule

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

Dobbs anniversary: the lost opportunity of abortion as health care

Listen: A conversation with researcher Kevin Esvelt on biosecurity

leisure time

AI generated plenty of interest at JPM but not a lot of trust

Medicare Advantage today, explained in one chart

FDA poised to publish guidelines for clinical trial diversity

Investigation reveals sickle cell patients pressured into sterilizations

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Humana cuts profit projections as Medicare Advantage costs soar

leisure time

explore

focus

focus